Nanoparticles enable targeted mRNA delivery to the pancreas
TL;DR
Researchers at UNLV have developed a novel nanoparticle system called ENDO that can selectively deliver mRNA directly to the pancreas by leveraging the body's Vitamin D receptors, potentially revolutionizing treatments for pancreatic diseases like diabetes and cancer with increased precision and fewer side effects.
Topics:healthscience#biomedical-research#mrna-delivery#nanoparticles#pancreas#science#targeted-therapy
Want the full story? Read the original reporting
Read on Phys.org